Log In
Print this Print this

Quinsair (MP-376) (formerly Aeroquin)

  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma plc
DescriptionAerosolized formulation of levofloxacin, a fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase
Molecular Target DNA gyrase ; Topoisomerase
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today